TRACON Pharmaceuticals, Inc.
TCON · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $5,708 | $31,169 | $47,790 | $104,956 |
| - Cash | $8,564 | $17,433 | $24,072 | $32,131 |
| + Debt | $968 | $9,807 | $1,391 | $4,527 |
| Enterprise Value | -$1,888 | $23,543 | $25,109 | $77,352 |
| Revenue | $12,045 | $0 | $346 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $12,031 | -$16 | $332 | -$12 |
| % Margin | 99.9% | – | 96% | – |
| EBITDA | -$6,884 | -$28,125 | -$28,333 | -$16,223 |
| % Margin | -57.2% | – | -8,188.7% | – |
| Net Income | -$3,588 | -$29,312 | -$28,726 | -$17,326 |
| % Margin | -29.8% | – | -8,302.3% | – |
| EPS Diluted | -2.19 | -28.02 | -33.3 | -38.57 |
| % Growth | 92.2% | 15.9% | 13.7% | – |
| Operating Cash Flow | $3,676 | -$26,239 | -$22,571 | -$17,042 |
| Capital Expenditures | $0 | -$17 | -$48 | -$5 |
| Free Cash Flow | $3,676 | -$26,256 | -$22,619 | -$17,047 |